These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 88215)

  • 1. Inosiplex in the treatment of subacute sclerosing panencephalitis.
    Silverberg R; Brenner T; Abramsky O
    Arch Neurol; 1979 Jun; 36(6):374-5. PubMed ID: 88215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of inosiplex in subacute sclerosing panencephalitis (SSPE)].
    Nihei K; Kudo H; Abe T; Naito H; Suzuki S; Miyao M
    No To Hattatsu; 1984 Jul; 16(4):262-70. PubMed ID: 6207848
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of inosiplex on the survival of subacute sclerosing panencephalitis.
    DuRant RH; Dyken PR
    Neurology; 1983 Aug; 33(8):1053-5. PubMed ID: 6192362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex.
    Dyken PR; Swift A; DuRant RH
    Ann Neurol; 1982 Apr; 11(4):359-64. PubMed ID: 6179455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of subacute sclerosing panencephalitis: an overview.
    Taylor WJ; DuRant RH; Dyken PR
    Drug Intell Clin Pharm; 1984 May; 18(5):375-81. PubMed ID: 6202474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients.
    Jones CE; Dyken PR; Huttenlocher PR; Jabbour JT; Maxwell KW
    Lancet; 1982 May; 1(8280):1034-7. PubMed ID: 6176821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inosiplex for SSPE.
    Jones C
    Lancet; 1982 Aug; 2(8296):495. PubMed ID: 6180266
    [No Abstract]   [Full Text] [Related]  

  • 8. Inosiplex for SSPE.
    Chalmers TC; Smith H
    Lancet; 1982 Jun; 1(8287):1475. PubMed ID: 6177984
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis.
    DuRant RH; Dyken PR; Swift AV
    J Pediatr; 1982 Aug; 101(2):288-93. PubMed ID: 6178812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis--a multi-institutional collaborative study--The Inosiplex-SSPE Research Committee.
    Fukuyama Y; Nihei K; Matsumoto S; Ebina T; Kamoshita S; Sato T; Arima M; Yabuuchi H; Ueda S; Ohtahara S
    Brain Dev; 1987; 9(3):270-82. PubMed ID: 2444125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoprimosine in subacute sclerosing panencephalitis.
    Alter M
    Neurology; 1980 Feb; 30(2):221-2. PubMed ID: 6153462
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE).
    Streletz LJ; Cracco J
    Ann Neurol; 1977 Feb; 1(2):183-4. PubMed ID: 70187
    [No Abstract]   [Full Text] [Related]  

  • 13. Inosiplex affects the spectra of proton magnetic resonance spectroscopy in subacute sclerosing panencephalitis.
    Kato Z; Asano T; Kondo N
    J Child Neurol; 2006 Feb; 21(2):177-8. PubMed ID: 16566890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.
    Haddad FS; Risk WS
    Ann Neurol; 1980 Feb; 7(2):185-8. PubMed ID: 6154441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive CT abnormalities despite clinical improvement in SSPE treated with inosiplex.
    Noetzel MJ; Dodson WE
    Ann Neurol; 1983 Apr; 13(4):457-60. PubMed ID: 6188412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.
    Solomon T; Hart CA; Vinjamuri S; Beeching NJ; Malucci C; Humphrey P
    J Child Neurol; 2002 Sep; 17(9):703-5. PubMed ID: 12503650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine].
    Filipowicz A; Grudzińska B
    Neurol Neurochir Pol; 1987; 21(4-5):352-6. PubMed ID: 2451185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of isoprinosine in subacute sclerosing panencephalitis.
    McGrath E; Rosenbloom L
    Arch Dis Child; 1980 Oct; 55(10):829-30. PubMed ID: 6159826
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis.
    Anlar B; Yalaz K; Köse G; Saygi S
    J Child Neurol; 1998 Nov; 13(11):557-9. PubMed ID: 9853649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical registers as historical controls: analysis of an open clinical trial of inosiplex in subacute sclerosing panencephalitis.
    Hoehler FK; Mantel N; Gehan E; Kahana E; Alter M
    Stat Med; 1984; 3(3):225-37. PubMed ID: 6207580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.